(Q33926171)

30 July 2017

1 reference

title

Women and HIV--revisited ten years on. (English)

1 reference

30 July 2017

R Shah

1

1 reference

30 July 2017

C Bradbeer

series ordinal

2

1 reference

30 July 2017

publication date

1 May 2000

1 reference

International Journal of STD & AIDS

30 July 2017

published in

1 reference

30 July 2017

volume

11

1 reference

30 July 2017

issue

5

1 reference

30 July 2017

page(s)

277-283

1 reference

Women and HIV. Epidemiology and global overview

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F095646240001100501

Cofactors in male-female sexual transmission of human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095646240001100501

Women, HIV, and mucosal immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095646240001100501

Heterosexual transmission of human immunodeficiency virus: variability of infectivity throughout the course of infection. European Study Group on Heterosexual Transmission of HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095646240001100501

Sexual intercourse during menstruation and self-reported sexually transmitted disease history among women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095646240001100501

The use of human immunodeficiency virus postexposure prophylaxis after successful artificial insemination

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095646240001100501

Rape and subsequent seroconversion to HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095646240001100501

Postexposure prophylaxis for human immunodeficiency virus (HIV) infection following sexual assault

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095646240001100501

Rape among African American women: sexual, psychological, and social correlates predisposing survivors to risk of STD/HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095646240001100501

High risk of HIV-1 infection for first-born twins. The International Registry of HIV-exposed Twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095646240001100501

Mothers of infants with the acquired immunodeficiency syndrome. Evidence for both symptomatic and asymptomatic carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095646240001100501

Risk of human immunodeficiency virus type 1 transmission through breastfeeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095646240001100501

Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095646240001100501

Obstetric factors and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohorts. SEROGEST French Pediatric HIV Infection Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095646240001100501

Epidemiology and detection of HIV-1 among pregnant women in the United Kingdom: results from national surveillance 1988-96

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095646240001100501

Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095646240001100501

The incidence of HIV infection among women using family planning methods in Dar es Salaam, Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095646240001100501

Complications of use of intrauterine devices among HIV-1-infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095646240001100501

Characteristics of menstruation in women infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095646240001100501

Sexually transmitted diseases and human immunodeficiency virus infection among women with pelvic inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095646240001100501

Chronic vaginal candidiasis in women with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095646240001100501

Activation of human immunodeficiency virus type 1 expression by Gardnerella vaginalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095646240001100501

Activation of human immunodeficiency virus by herpes simplex virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095646240001100501

The increased frequency of cervical dysplasia-neoplasia in women infected with the human immunodeficiency virus is related to the degree of immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095646240001100501

Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095646240001100501

Vertical transmission of Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095646240001100501

Category of exposure to HIV and age in the progression to AIDS: longitudinal study of 1199 people with known dates of seroconversion. HIV Italian Seroconversion Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095646240001100501

Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095646240001100501

Sex differences in HIV-1 viral load and progression to AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095646240001100501

The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095646240001100501

Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095646240001100501

Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095646240001100501

Unconventional conceptions and HIV

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095646240001100501

Kaposi's sarcoma in women with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095646240001100501

10.1177/095646240001100501

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference